VANGUARD GROUP INC 13D and 13G filings for AnaptysBio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:43 pm Sale | 2026-03-13 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 0 0.000% | -2,306,325 (Position Closed) | Filing |
| 2025-07-29 11:23 am Purchase | 2025-06-30 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,306,325 5.230% | 30,337 (+1.33%) | Filing |
| 2025-04-30 10:57 am Purchase | 2025-03-31 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,275,988 4.940% | 205,816 (+9.94%) | Filing |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,070,172 5.190% | -595,190 (-22.33%) | Filing |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,665,362 6.250% | -98,662 (-3.57%) | Filing |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,764,024 6.670% | -566,458 (-17.01%) | Filing |